Cerebral Microembolization Associated With PFO Closure

Recruiting Observational Study
Thrombosis Cardiac Atrial Septal Defect Patent Foramen Ovale (PFO)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to investigate (1) the de novo cerebral microembolization in patients who undergo transcatheter closure of PFO or ASD, and (2) evaluate the relationship between de novo cerebral microembolization and in situ thrombus within PFO.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
PFO group Inclusion Criteria: 1\) age 18 to 65 years; 2) documented PFO with medium-to-large shunts (≥ 20 microbubbles by c-TCD at rest or during the Valsalva maneuver); 3) history of embolic stroke (based on brain magnetic resonance imaging within 24 hours after symptom onset) or TIA within 6 mon…
Contacts

Chaowu Yan, PhD MD

13811967138

chaowuyan@163.com

CONTACT